sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
DNA sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Other Applications), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-Time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017 - 2025

DNA sequencing Market by Product (Consumable, Instrument, and Service) Application...

Home / Categories / Healthcare
DNA sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Other Applications), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-Time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017 - 2025
DNA sequencing Market by Product...
Report Code
RO1/113/1441

Publish Date
18/Dec/2018

Pages
310
PRICE
$ 5370/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 6450/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 8995/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets

3.3. Top winning strategies
3.4. Market share analysis

3.4.1. Overview

3.5. Patents analysis

3.5.1. Patent analysis, by region
3.5.2. Patent analysis, by year

3.6. Porters five forces analysis
3.7. Market dynamics

3.7.1. Drivers

3.7.1.1. Technological advancements in DNA sequencing
3.7.1.2. Surge in applications of DNA sequencing
3.7.1.3. Increase in partnerships and collaborations
3.7.1.4. Increase in genome mapping programs

3.7.2. Restraints

3.7.2.1. Standardization concerns over DNA sequencing-based diagnostics
3.7.2.2. Dearth of skilled professionals
3.7.2.3. Ethical and legal limitations

3.7.3. Opportunities

3.7.3.1. Lucrative opportunities in emerging markets
3.7.3.2. Cloud computing as a potential data management service

3.7.4. Impact analyses

CHAPTER 4: DNA SEQUENCING MARKET, BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast

4.2. Consumables

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country

4.3. Instruments

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

4.4. Services

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country

CHAPTER 5: DNA SEQUENCING MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Biomarker & cancer

5.2.1. Market size and forecast, by region
5.2.2. Market share analysis

5.3. Diagnostics

5.3.1. Market size and forecast, by region
5.3.2. Market share analysis, by country

5.4. Reproductive health

5.4.1. Market size and forecast, by region
5.4.2. Market share analysis, by country

5.5. Personalized medicine

5.5.1. Market size and forecast, by region
5.5.2. Market share analysis, by country

5.6. Forensics

5.6.1. Market size and forecast, by region
5.6.2. Market share analysis

5.7. Others

5.7.1. Market size and forecast, by region
5.7.2. Market share analysis

CHAPTER 6: DNA SEQUENCING MARKET, BY TECHNOLOGY

6.1. Overview

6.1.1. Market size and forecast

6.2. Sequencing by synthesis

6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country

6.3. Ion semiconductor sequencing

6.3.1. Market size and forecast, by region
6.3.2. Market share analysis, by country

6.4. Sequencing by ligation

6.4.1. Market size and forecast, by region
6.4.2. Market share analysis, by country

6.5. Pyrosequencing

6.5.1. Market size and forecast, by region
6.5.2. Market share analysis, by country

6.6. Single-molecule real-time sequencing

6.6.1. Market size and forecast, by region
6.6.2. Market share analysis, by country

6.7. Chain termination technology

6.7.1. Market size and forecast, by region
6.7.2. Market share analysis, by country

6.8. Nanopore sequencing

6.8.1. Market size and forecast, by region
6.8.2. Market share analysis, by country

CHAPTER 7: DNA SEQUENCING MARKET, BY END USER

7.1. Overview

7.1.1. Market size and forecast

7.2. Academic & government research institute

7.2.1. Market size and forecast, by region
7.2.2. Market share analysis, by country

7.3. Pharmaceutical companies

7.3.1. Market size and forecast, by region
7.3.2. Market share analysis, by country

7.4. Biotechnology companies

7.4.1. Market size and forecast, by region
7.4.2. Market share analysis

7.5. Hospital & clinics

7.5.1. Market size and forecast, by region
7.5.2. Market share analysis

CHAPTER 8: DNA SEQUENCING MARKET, BY REGION

8.1. Overview

8.1.1. Market size and forecast

8.2. North America

8.2.1. Key market trends, growth factors, and opportunities
8.2.2. Market size and forecast, by country

8.2.2.1. U.S.

8.2.2.1.1. U.S. DNA sequencing market, by product
8.2.2.1.2. U.S. DNA sequencing market, by application
8.2.2.1.3. U.S. DNA sequencing market, by technology
8.2.2.1.4. U.S. DNA sequencing market, by end user

8.2.2.2. Canada

8.2.2.2.1. Canada DNA sequencing market, by product
8.2.2.2.2. Canada DNA sequencing market, by application
8.2.2.2.3. Canada DNA sequencing market, by technology
8.2.2.2.4. Canada DNA sequencing market, by end user

8.2.2.3. Mexico

8.2.2.3.1. Mexico DNA sequencing market, by product
8.2.2.3.2. Mexico DNA sequencing market, by application
8.2.2.3.3. Mexico DNA sequencing market, by technology
8.2.2.3.4. Mexico DNA sequencing market, by end user

8.2.3. Market size and forecast, by product
8.2.4. Market size and forecast, by application
8.2.5. Market size and forecast, by technology
8.2.6. Market size and forecast, by end user

8.3. Europe

8.3.1. Key market trends, growth factors, and opportunities
8.3.2. Market size and forecast, by country

8.3.2.1. Germany

8.3.2.1.1. Germany DNA sequencing market, by product
8.3.2.1.2. Germany DNA sequencing market, by application
8.3.2.1.3. Germany DNA sequencing market, by technology
8.3.2.1.4. Germany DNA sequencing market, by end user

8.3.2.2. France

8.3.2.2.1. France DNA sequencing market, by product
8.3.2.2.2. France DNA sequencing market, by application
8.3.2.2.3. France DNA sequencing market, by technology
8.3.2.2.4. France DNA sequencing market, by end user

8.3.2.3. UK

8.3.2.3.1. UK DNA sequencing market, by product
8.3.2.3.2. UK DNA sequencing market, by application
8.3.2.3.3. UK DNA sequencing market, by technology
8.3.2.3.4. UK DNA sequencing market, by end user

8.3.2.4. Italy

8.3.2.4.1. Italy DNA sequencing market, by product
8.3.2.4.2. Italy DNA sequencing market, by application
8.3.2.4.3. Italy DNA sequencing market, by technology
8.3.2.4.4. Italy DNA sequencing market, by end user

8.3.2.5. Spain

8.3.2.5.1. Spain DNA sequencing market, by product
8.3.2.5.2. Spain DNA sequencing market, by application
8.3.2.5.3. Spain DNA sequencing market, by technology
8.3.2.5.4. Spain DNA sequencing market, by end user

8.3.2.6. Rest of Europe

8.3.2.6.1. Rest of Europe DNA sequencing market, by product
8.3.2.6.2. Rest of Europe DNA sequencing market, by application
8.3.2.6.3. Rest of Europe DNA sequencing market, by technology
8.3.2.6.4. Rest of Europe DNA sequencing market, by end user

8.3.3. Market size and forecast, by product
8.3.4. Market size and forecast, by application
8.3.5. Market size and forecast, by technology
8.3.6. Market size and forecast, by end user

8.4. Asia-Pacific

8.4.1. Key market trends, growth factors, and opportunities
8.4.2. Market size and forecast, by country

8.4.2.1. Japan

8.4.2.1.1. Japan DNA sequencing market, by product
8.4.2.1.2. Japan DNA sequencing market, by application
8.4.2.1.3. Japan DNA sequencing market, by technology
8.4.2.1.4. Japan DNA sequencing market, by end user

8.4.2.2. China

8.4.2.2.1. China DNA sequencing market, by product
8.4.2.2.2. China DNA sequencing market, by application
8.4.2.2.3. China DNA sequencing market, by technology
8.4.2.2.4. China DNA sequencing market, by end user

8.4.2.3. Australia

8.4.2.3.1. Australia DNA sequencing market, by product
8.4.2.3.2. Australia DNA sequencing market, by application
8.4.2.3.3. Australia DNA sequencing market, by technology
8.4.2.3.4. Australia DNA sequencing market, by end user

8.4.2.4. India

8.4.2.4.1. India DNA sequencing market, by product
8.4.2.4.2. India DNA sequencing market, by application
8.4.2.4.3. India DNA sequencing market, by technology
8.4.2.4.4. India DNA sequencing market, by end user

8.4.2.5. South Korea

8.4.2.5.1. South Korea DNA sequencing market, by product
8.4.2.5.2. South Korea DNA sequencing market, by application
8.4.2.5.3. South Korea DNA sequencing market, by technology
8.4.2.5.4. South Korea DNA sequencing market, by end user

8.4.2.6. Taiwan

8.4.2.6.1. Taiwan DNA sequencing market, by product
8.4.2.6.2. Taiwan DNA sequencing market, by application
8.4.2.6.3. Taiwan DNA sequencing market, by technology
8.4.2.6.4. Taiwan DNA sequencing market, by end user

8.4.2.7. Rest of Asia-Pacific

8.4.2.7.1. Rest of Asia-Pacific DNA sequencing market, by product
8.4.2.7.2. Rest of Asia-Pacific DNA sequencing market, by application
8.4.2.7.3. Rest of Asia-Pacific DNA sequencing market, by technology
8.4.2.7.4. Rest of Asia-Pacific DNA sequencing market, by end user

8.4.3. Market size and forecast, by product
8.4.4. Market size and forecast, by application
8.4.5. Market size and forecast, by technology
8.4.6. Market size and forecast, by end user

8.5. LAMEA

8.5.1. Key market trends, growth factors, and opportunities
8.5.2. Market size and forecast, by country

8.5.2.1. Brazil

8.5.2.1.1. Brazil DNA sequencing market, by product
8.5.2.1.2. Brazil DNA sequencing market, by application
8.5.2.1.3. Brazil DNA sequencing market, by technology
8.5.2.1.4. Brazil DNA sequencing market, by end user

8.5.2.2. Turkey

8.5.2.2.1. Turkey DNA sequencing market, by product
8.5.2.2.2. Turkey DNA sequencing market, by application
8.5.2.2.3. Turkey DNA sequencing market, by technology
8.5.2.2.4. Turkey DNA sequencing market, by end user

8.5.2.3. Saudi Arabia

8.5.2.3.1. Saudi Arabia DNA sequencing market, by product
8.5.2.3.2. Saudi Arabia DNA sequencing market, by application
8.5.2.3.3. Saudi Arabia DNA sequencing market, by technology
8.5.2.3.4. Saudi Arabia DNA sequencing market, by end user

8.5.2.4. Rest of LAMEA

8.5.2.4.1. Rest of LAMEA DNA sequencing market, by product
8.5.2.4.2. Rest of LAMEA DNA sequencing market, by application
8.5.2.4.3. Rest of LAMEA DNA sequencing market, by technology
8.5.2.4.4. Rest of LAMEA DNA sequencing market, by end user

8.5.3. Market size and forecast, by product
8.5.4. Market size and forecast, by application
8.5.5. Market size and forecast, by technology
8.5.6. Market size and forecast, by end user

CHAPTER 9: COMPANY PROFILES

9.1. ABBOTT LABORATORIES

9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.1.5. Business performance

9.2. AGILENT TECHNOLOGIES, INC.

9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio
9.2.5. Business performance
9.2.6. Key strategic moves and developments

9.3. DANAHER CORPORATION (BECKMAN COULTER, INC.)

9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.3.5. Business performance

9.4. F. HOFFMANN-LA ROCHE LTD.

9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Business performance
9.4.6. Key strategic moves and developments

9.5. ILLUMINA, INC.

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product Portfolio
9.5.5. Business performance
9.5.6. Key strategic moves and developments

9.6. LI-COR, INC.

9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio

9.7. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.7.5. Business performance
9.7.6. Key strategic moves and developments

9.8. PERKINELMER INC.

9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product Portfolio
9.8.5. Business performance

9.9. SIEMENS AG

9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Business performance

9.10. THERMO FISHER SCIENTIFIC, INC.

9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance
9.10.6. Key strategic moves and developments

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com